By Emeritus Professor Andrew Lloyd

Books

, 2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn

Book Chapters

Lloyd AR; Hickie I; Wakefield D, 2022, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology Third Edition, pp. 371 - 383, http://dx.doi.org/10.1128/9781555815981.ch17

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, pp. 1083 - 1096

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in Principles and Practice of Q Fever the One Health Paradigm, pp. 301 - 315

Lloyd A, 2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Lloyd AR, 2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1

Oldmeadow M; Lloyd AROLA, 2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia

Dore GJ; Temple-Smith M; Lloyd AROLA, 2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/

Oldmeadow M; Lloyd AR, 2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204

Lloyd AR; Hickie IB; Petersen PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159

Lloyd AR; Hickie IB; Peterson PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Wakefield D, 1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, Marcel Dekker, New York, pp. 267 - 274

DWYER JM; LLOYD AR; HICKIE IB; WAKEFIELD D; BOUGHTON CR, 1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7

Journal articles

Maduranga S; Valencia BM; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Rapadas M; Deveson IW; Lloyd AR; Bull R; Rodrigo C, 2026, 'Between- and within-host mutation of dengue virus', Virology, 615, http://dx.doi.org/10.1016/j.virol.2025.110750

Rothhaar P; Arand T; Seong HGT; Heuss C; Tulessin M; Wang Z; Förster C; Schneider AC; Quistrebert J; Chai H; Reineke M; Benning L; Honegger J; Hofmann M; Thimme R; Timm J; Schnitzler P; Merle U; Shoukry NH; Bruneau J; Rodrigo C; Lloyd A; Bull RA; Ansari MA; Mogler C; McLauchlan J; Forns X; Pérez-Del-Pulgar S; Lohmann V, 2025, 'Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease', Nature Communications, 16, pp. 10948, http://dx.doi.org/10.1038/s41467-025-67174-w

Horsburgh BA; Abayasingam A; Jenkins F; Li H; Foster CSP; Lloyd A; Coin L; Rawlinson W; Kelleher AD; van Hal S; Bull RA; Di Giallonardo F; Stephenson R; Williams R; Cunningham P; Turra M; Douglas MW; Leong L; McNally LP; Caly L; Dragasevich L; Jackson K; Farrell J; Kok J; Taiaroa G; Williams E; Chibo D; Dwyer D; Rodrigo C; Sevendal A; Castley A, 2025, 'Development and verification of a novel tiling PCR method for long-range HIV-1 sequencing in a diagnostic setting', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-03190-6

Zhao Y; Keoshkerian E; Li H; Sacks-David R; Boo I; Dietze P; Hellard M; Drummer H; Luciani F; Bull RA; Lloyd AR, 2025, 'Functional Antigen-Specific CD8 TSCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection', European Journal of Immunology, 55, http://dx.doi.org/10.1002/eji.70098

Montague C; Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study', International Journal of Drug Policy, 146, http://dx.doi.org/10.1016/j.drugpo.2025.105035

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2025, 'Using the socioecological model to guide service delivery improvements to the prison needle exchange program in Canada: insights from multi-level stakeholders', BMC Public Health, 25, http://dx.doi.org/10.1186/s12889-025-24935-y

Zhao Y; Samir J; Keoshkerian E; Li H; An H; Bull RA; Luciani F; Lloyd AR, 2025, 'Progenitor effects and unique transcriptomic signatures linked to differentiation phenotype in clonally expanded antigen-specific CD8 T memory stem cells', JOURNAL OF IMMUNOLOGY, http://dx.doi.org/10.1093/jimmun/vkaf299

Raijmakers RPH; Lund Berven L; Keijmel SP; Rodrigo C; Wyller VBB; Katz BZ; Buchwald D; Evans RA; Gérardin P; Knoop H; Prins M; Stavem K; Stiansen-Sonerud T; Taylor R; Valencia Arroyo BM; Wensaas KA; Selvakumar JP; van den Wijngaard C; Lloyd AR; Sandler CX, 2025, 'Immunological associations in post-infective fatigue syndromes including Long COVID—a systematic review and meta-analysis', Ebiomedicine, 121, http://dx.doi.org/10.1016/j.ebiom.2025.105970

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, 144, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Harrison F; Mortby ME; Lloyd AR; Guastella AJ; Trollor JN; Sachdev PS; Brodaty H, 2025, 'Apathy is distinct from depression or fatigue and is associated with poor physical health in an older community cohort', International Psychogeriatrics, 37, http://dx.doi.org/10.1016/j.inpsyc.2025.100089

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Walker MR; Leung P; Keoshkerian E; Pirozyan MR; Lloyd A; Luciani F; Bull RA, 2025, 'Temporal dynamics of viral fitness and the adaptive immune response in HCV infection', ELIFE, 13, http://dx.doi.org/10.7554/eLife.102232

Walker MR; Leung P; Keoshkerian E; Pirozyan MR; Lloyd A; Luciani F; Bull RA, 2025, 'Temporal dynamics of viral fitness and the adaptive immune response in HCV infection', eLife, 13, http://dx.doi.org/10.7554/elife.102232.3

Lafferty L; Brown T; McGrath C; Wright T; Henderson C; Lloyd AR; Grebely J; Treloar C, 2025, 'Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study', International Journal of Drug Policy, 142, pp. 104831 - 104831, http://dx.doi.org/10.1016/j.drugpo.2025.104831

Legrand NM; Bull RA; Hajarizadeh B; Lloyd AR; Johnston K; Issa K; Harvey C; Arnott A; Dwyer DE; Sintchenko V; Grant L; Dore GJ; Kaldor J; Martinello M, 2025, 'Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia', Emerging Infectious Diseases, 31, pp. 1527 - 1536, http://dx.doi.org/10.3201/eid3108.240571

Kabir KMA; Sigera C; Maduranga S; Weeratunga P; Rajapakse S; Fernando D; Lloyd AR; Bull RA; Rodrigo C, 2025, 'Chikungunya masquerading as dengue infection in Sri Lanka uncovered by metagenomics', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0326995

Jamali E; Quadeer AA; Tedla N; McKay MR; Lloyd A; Walker MR; Bull RA, 2025, 'Anti-HCV antibodies: A battle for breadth and potency', Antiviral Research, 238, http://dx.doi.org/10.1016/j.antiviral.2025.106165

Tonini E; Crouse JJ; Shin M; Carpenter JS; Lloyd AR; Hindmarsh G; McKenna S; Nichles A; Zmicerevska N; Scott J; Iorfino F; Pantelis C; Nelson B; McGorry PD; Wood SJ; Yung AR; Purcell R; Hickie IB, 2025, 'Multidimensional outcomes associated with chronic fatigue over 12 months in youth with emerging mood disorders', Journal of Psychosomatic Research, 193, http://dx.doi.org/10.1016/j.jpsychores.2025.112141

Kiziloz S; Ward EJ; Hawthorne D; Sinha A; Cooksley G; Sarker D; Crua C; Lloyd A; Shuck CE; Gogotsi Y; Sandeman S, 2025, 'Ti₃C₂T_x MXene augments osmo-adaptive repression of the inflammatory stress response for improved wound repair', NANOSCALE, 17, pp. 12758 - 12774, http://dx.doi.org/10.1039/d4nr04622f

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Maduranga S; Shrestha LB; Valencia BM; Horton G; Guppy M; Gidding HF; Graves S; Stenos J; Rawlinson W; Lloyd AR; Rodrigo C, 2025, 'Diagnosing and Preventing Q Fever in Regional New South Wales, Australia—A Qualitative Exploration of Perspectives of General Practitioners', Australian Journal of Rural Health, 33, http://dx.doi.org/10.1111/ajr.70030

Li V; McKay FC; Tscharke DC; Smith C; Khanna R; Lechner-Scott J; Rawlinson WD; Lloyd AR; Taylor BV; Morahan JM; Steinman L; Giovannoni G; Bar-Or A; Levy M; Drosu N; Potter A; Caswell N; Smith L; Brady EC; Frost B; Hodgkinson S; Hardy TA; Broadley SA, 2025, 'Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach', CNS Drugs, 39, pp. 305 - 320, http://dx.doi.org/10.1007/s40263-024-01153-5

Moallemi S; Tedla N; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Lloyd AR; Rodrigo C, 2025, 'Early circulating biomarkers to predict plasma leakage in dengue fever', Journal of Infection, 90, http://dx.doi.org/10.1016/j.jinf.2024.106401

Sheehan Y; Garg A; Sheehan J; Maduka N; Altice FL; Alves da Costa F; Cox S; Elsharkawy AM; Salah E; Stoové M; Tavoschi L; Thompson AJ; Thornton K; Lloyd AR; Cabezas J; Akiyama MJ; Kronfli N, 2025, 'Best practice guidelines for viral hepatitis service delivery in prisons', Lancet Infectious Diseases, http://dx.doi.org/10.1016/S1473-3099(25)00630-9

Richardson A; Corley S; Delic N; Li H; Lloyd A; Di Girolamo N, 2025, 'Single-Cell RNA Sequencing of Murine Limbal Epithelia Reveals Gas1 as a Novel Stem/Progenitor Cell Marker for the Corneal Epithelium', Cornea, http://dx.doi.org/10.1097/ICO.0000000000003938

Gervais A; Bastard P; Bizien L; Delifer C; Tiberghien P; Rodrigo C; Trespidi F; Angelini M; Rossini G; Lazzarotto T; Conti F; Cassaniti I; Baldanti F; Rovida F; Ferrari A; Mileto D; Mancon A; Abel L; Puel A; Cobat A; Rice CM; Cadar D; Schmidt-Chanasit J; Scheid JF; Lemieux JE; Rosenberg ES; Agudelo M; Tangye SG; Borghesi A; Durand GA; Duburcq-Gury E; Valencia BM; Lloyd AR; Nagy A; Macdonald MM; Simonin Y; Zhang SY; Casanova JL, 2024, 'Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease', Journal of Experimental Medicine, 221, http://dx.doi.org/10.1084/jem.20240942

Shrestha LB; Tungatt K; Aggarwal A; Stubis A; Fewings NL; Fichter C; Akerman A; Rodrigo C; Tedla N; Lee S; Lloyd AR; Brilot F; Britton WJ; Kelleher A; Caterson ID; Douglas MW; Rockett R; Tangye SG; Triccas JA; Turville SG; Sandgren KJ; Bull RA; Cunningham AL; Sorrell T; Maclean M; Camilleri J; Douglas M; Song Y; Mao L; Phu A; Sigmund A; Beard S; Hunt S; Vande More AM; Kandasamy R; Kok J; Byrne J; Lloyd A; Tangye S; O'Sullivan M; Steain M; Baird S; Phetsouphanh C; Zhao Y, 2024, 'Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105461

Walker SJ; Dawson O; Sheehan Y; Shrestha LB; Lloyd AR; Sheehan J; Maduka N; Cabezas J; Kronfli N; Akiyama MJ, 2024, 'Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework', International Journal of Drug Policy, 134, http://dx.doi.org/10.1016/j.drugpo.2024.104628

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Nibau C; Evans A; King H; Phillips DW; Lloyd A, 2024, 'Homoeologous crossovers are distally biased and underlie genomic instability in first-generation neo-allopolyploid Arabidopsis suecica', New Phytologist, 244, pp. 1315 - 1327, http://dx.doi.org/10.1111/nph.20095

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004

Back to profile page